Genmab AS（GMAB）— 技术面状态
数据截至2026-10-12 — 每个交易日晚间对全部覆盖范围重新计算。Closelook研究日记，不构成投资建议。
Trades +10.9% vs the 50-day and +25.5% vs the 200-day average, 7% below the 52-week high and +58.2% off the 52-week low; a golden cross printed 33 sessions ago. Computed from daily closes.
Ranked #48 on today’s Directional Flow — Rising fastest list (scan of 2026-10-12).
均线状态
- 相对20日均线+5%
- 相对50日均线+10.9%
- 相对200日均线+25.5%
- 52周区间低于52周高点7% · 高于52周低点58.2%
- 连续走势连续2个交易日上涨
- 均线交叉金叉（33个交易日前）
- 50日均线交叉股价向上穿越50日均线（72个交易日前）
- 随机指标%K 56.6 · %D 44.5（金叉）
FAQ · from the current data · as of 2026-10-12
Quick answers
GMAB当前的Closelook信号是什么？
Uptrend stack intact — Trades +10.9% vs the 50-day and +25.5% vs the 200-day average, 7% below the 52-week high and +58.2% off the 52-week low; a golden cross printed 33 sessions ago. Computed from daily closes.（截至2026-10-12；信号看板每个交易日晚间对全部覆盖范围重新计算。研究日记读数，不构成投资建议。）
GMAB目前是否位于50日和200日均线上方？
截至2026-10-12，Genmab AS位于50日均线上方（+10.9%），200日均线上方（+25.5%）；距20日均线+5%。
GMAB距52周高点有多远？
截至2026-10-12，低于52周高点7%，高于52周低点58.2%。
Related in the Closelooknet universe
then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- HALO Halozyme Therapeutics Incindustry
- ARGX.BR Argen-Xindustry
- ONC BeiGene, Ltd.industry
- ARGX argenx NV ADRindustry
- KRYS Krystal Biotech Incindustry
- PTGX Protagonist Therapeutics Incindustry
- MRNA Moderna Incindustry
- DNA Ginkgo Bioworks Holdingsindustry
- ONT.L Oxford Nanopore Technologies Ltdindustry
- CAI Caris Life Sciences, Inc. Common Stockindustry
- RXRX Recursion Pharmaceuticals Incindustry
- EXEL Exelixis Incindustry
- TWST Twist Bioscience Corpindustry
- TECH Bio-Techne Corpindustry
- MRVI Maravai Lifesciences Holdings Incindustry
- RPRX Royalty Pharma Plcindustry
- BION.SW BB Biotech AGindustry
- INCY Incyte Corporationindustry
- JAZZ Jazz Pharmaceuticals PLCindustry
- NTLA Intellia Therapeutics Incindustry